Rational development of a serum-free medium and fed-batch process for a GS-CHO cell line expressing recombinant antibody.
about
Better and faster: improvements and optimization for mammalian recombinant protein productionMultifactorial interaction of growth factors on Penaeus monodon lymphoid cells and the impact of IGFs in DNA synthesis and metabolic activity in vitro.A Single Dynamic Metabolic Model Can Describe mAb Producing CHO Cell Batch and Fed-Batch Cultures on Different Culture Media.Designed Amino Acid Feed in Improvement of Production and Quality Targets of a Therapeutic Monoclonal Antibody.Optimization of bioprocess conditions improves production of a CHO cell-derived, bioengineered heparinTailoring recombinant protein quality by rational media design.The enhancement of antibody concentration and achievement of high cell density CHO cell cultivation by adding nucleoside.Effects of Peptone Supplementation in Different Culture Media on Growth, Metabolic Pathway and Productivity of CHO DG44 Cells; a New Insight into Amino Acid Profiles.A framework for the systematic design of fed-batch strategies in mammalian cell culture.Amino acid consumption in naïve and recombinant CHO cell cultures: producers of a monoclonal antibodyA simultaneous assessment metric for MAb quantity and glycan quality.A high-throughput media design approach for high performance mammalian fed-batch cultures.Design of serum-free medium for suspension culture of CHO cells on the basis of general commercial media.Examining the sources of variability in cell culture media used for biopharmaceutical production.Trends in Upstream and Downstream Process Development for Antibody Manufacturing.Fed-Batch CHO Cell Culture for Lab-Scale Antibody Production.Arginine as an eluent overcomes the hindrance of monoclonal antibody quantification by dextran sulfate in protein A affinity chromatography.
P2860
Q27005759-3537512C-2B39-47E4-BE28-5955EAB838C3Q35211511-3F1E0C92-09BD-4C52-B4BF-F66ACF8AB22FQ35762155-7FB97F8E-9152-49E2-98AE-7F097F444936Q35812440-2FD5660F-A26A-4E8F-8042-FCD64B251225Q36015630-2BCE45D3-E435-4C15-83F6-EFC986F51276Q38416739-7A510252-14B0-4193-BB89-9B5814D846C6Q38714263-E0FEB440-162F-4BFC-8413-9BC25001BDCBQ38847423-3515261F-2AF5-4088-9D2D-9FC38D358E05Q38979911-24BBDF2B-E63B-4CFE-A0B2-E7A53DC910DEQ38998231-19AC496F-D524-42D4-B52B-1196A514DACFQ41639511-F6670525-FA47-4236-A00D-182AF7EDA930Q41897098-4F61C4E2-D3BA-4BFE-BE01-C1708A490792Q42415950-E42EC902-23A2-449B-BD59-64225F0F2E84Q47644503-951955B4-84CF-4140-910D-7652E4A8FE92Q47843398-C7E55019-F383-418B-A55C-D85B8409A799Q50046034-4C72E661-C1D9-49E9-B480-E6C35B19D57AQ51722429-D4DB94C5-8620-4901-BA8D-9BA19A7951F9
P2860
Rational development of a serum-free medium and fed-batch process for a GS-CHO cell line expressing recombinant antibody.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Rational development of a seru ...... pressing recombinant antibody.
@ast
Rational development of a seru ...... pressing recombinant antibody.
@en
type
label
Rational development of a seru ...... pressing recombinant antibody.
@ast
Rational development of a seru ...... pressing recombinant antibody.
@en
prefLabel
Rational development of a seru ...... pressing recombinant antibody.
@ast
Rational development of a seru ...... pressing recombinant antibody.
@en
P2093
P2860
P1433
P1476
Rational development of a seru ...... pressing recombinant antibody.
@en
P2093
Haibin Wang
Huifeng Zhang
Wensheng Xiang
Xiangjing Wang
P2860
P2888
P304
P356
10.1007/S10616-012-9488-4
P577
2012-08-21T00:00:00Z